Simon X Benito Inovio Pharmaceuticals, Inc. (INO) insider trading activity

INO Quotes by TradingView

Simon X Benito is Director of INOVIO PHARMACEUTICALS, INC.. Currently has a direct ownership of 12,191 shares of INO, which is worth approximately $24,991. The most recent transaction as insider was on May 21, 2025, when has been sold 2,167 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.2K
0% 3M change
21.62% 12M change
Total Value Held $24,991

SIMON X BENITO Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2025
BUY
Exercise of conversion of derivative security
-
2,167 Added 15.09%
12,191 Common Stock
May 15 2024
BUY
Exercise of conversion of derivative security
-
2,166 Added 17.77%
10,024 Common Stock
May 16 2023
BUY
Exercise of conversion of derivative security
-
19,000 Added 16.77%
94,305 Common Stock
Jul 20 2022
SELL
Open market or private sale
$4,500 $2.25 p/Share
2,000 Reduced 2.59%
75,305 Common Stock
Jul 20 2022
BUY
Exercise of conversion of derivative security
$4,400 $2.2 p/Share
2,000 Added 2.52%
77,305 Common Stock
May 13 2022
BUY
Exercise of conversion of derivative security
-
18,000 Added 19.29%
75,305 Common Stock
Mar 16 2022
SELL
Open market or private sale
$6,320 $3.16 p/Share
2,000 Reduced 3.37%
57,305 Common Stock
Mar 16 2022
BUY
Exercise of conversion of derivative security
$4,400 $2.2 p/Share
2,000 Added 3.26%
59,305 Common Stock
Jan 19 2022
SELL
Open market or private sale
$8,540 $4.27 p/Share
2,000 Reduced 3.37%
57,305 Common Stock
Jan 19 2022
BUY
Exercise of conversion of derivative security
$4,400 $2.2 p/Share
2,000 Added 3.26%
59,305 Common Stock
May 17 2021
SELL
Open market or private sale
$20,158 $6.62 p/Share
3,045 Reduced 5.05%
57,305 Common Stock
May 14 2021
BUY
Exercise of conversion of derivative security
-
8,700 Added 12.6%
60,350 Common Stock
Apr 16 2021
SELL
Open market or private sale
$17,500 $8.75 p/Share
2,000 Reduced 3.73%
51,650 Common Stock
Apr 16 2021
BUY
Exercise of conversion of derivative security
$7,120 $3.56 p/Share
2,000 Added 3.59%
53,650 Common Stock
Mar 16 2021
SELL
Open market or private sale
$20,820 $10.41 p/Share
2,000 Reduced 3.73%
51,650 Common Stock
Mar 16 2021
BUY
Exercise of conversion of derivative security
$7,120 $3.56 p/Share
2,000 Added 3.59%
53,650 Common Stock
Feb 16 2021
SELL
Open market or private sale
$29,360 $14.68 p/Share
2,000 Reduced 3.73%
51,650 Common Stock
Feb 16 2021
BUY
Exercise of conversion of derivative security
$7,120 $3.56 p/Share
2,000 Added 3.59%
53,650 Common Stock
Jan 04 2021
SELL
Open market or private sale
$24,750 $9.0 p/Share
2,750 Reduced 5.06%
51,650 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
$9,790 $3.56 p/Share
2,750 Added 4.81%
54,400 Common Stock

Also insider at

DRRX
DURECT CORP Healthcare
Director
SXB

Simon X Benito

Director
Plymouth Meeting, PA

Track Institutional and Insider Activities on INO

Follow INOVIO PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INO shares.

Notify only if

Insider Trading

Get notified when an Inovio Pharmaceuticals, Inc. insider buys or sells INO shares.

Notify only if

News

Receive news related to INOVIO PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INO